Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Moore Stephens
Structure assets to minimise fees and understand the corresponding Centrelink benefits, tax and estate planning issues.
Foley & Lardner
This post is the second in Foley’s blogs on China telemedicine and the first in the blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We hope to expand the series to include additional issues.
Foley & Lardner
Telemedicine providers and vendors doing business in China, whether based in China, the United States, or elsewhere, received new guidance on the use of telemedicine.
Jones Day
Two individuals will be prosecuted shortly in Shanghai for conducting illegal investigations and purchase of personal information in China.
Jones Day
China continues to struggle in its efforts to improve food safety regulation and oversight, in the wake of a succession of food safety problems.
Ropes & Gray LLP
The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime.
King & Wood Mallesons
This newsletter discusses the differences between the Amendment and the Revised Amendment, and the underlying rationale.
DaHui Lawyers
A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
This article outlines the implications of the new Free Trade Agreement between China and Switzerland in relation to the trade in medical devices.
King & Wood Mallesons
The China FDA has recently promulgated the Provisions on the Food and Drug Administrative Penalty Procedure.
King & Wood Mallesons
The Revised Regulations will come into effective on 1 June 2014, presenting some major changes.
Benesch Law
On December 26, 2013, the Commission promulgated Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry Circular [2013] No. 49.
MWE China Law Offices
The State Council of the Chinese Central Government unveiled a revised Regulation on the Supervision and Administration of Medical Devices.
Sheppard Mullin Richter & Hampton
The Regulations on Supervision and Administration of Medical Devices was amended and promulgated by the State Council, effective June 1st, 2014.
Sheppard Mullin Richter & Hampton
On December 25, 2013, the National Health and Family Planning Commission of China issued the amended "Provisions Regarding the Establishment of Commercial Bribery Blacklist in the Pharmaceutical Purchase and Sales Industries", which came into effect on March 1, 2014.
King & Wood Mallesons
The NHFPC has strengthened the healthcare industry to crack down on commercial bribery and illegal medical practices.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
On March 1, 2014, Circular No. 50 went into effect, promulgated to regulate the conduct of pharmaceutical and medical device companies that do business in China.
Ropes & Gray LLP
On February 7, 2014, the China Food and Drug Administration promulgated a notice titled "The Fast Track Approval Process for Innovative Medical Device (Tentative)", effective as of March 1, 2014.
Mayer Brown JSM
The Pharmacy and Poisons (Amendment) Bill 2014 ("Bill") was introduced in March 2014. The Bill proposes substantial changes aimed at improving and updating the regulatory framework of the Pharmacy and Poisons Ordinance.
Nishith Desai Associates
The Allahabad High Court observed that plain packaging of cigarettes and other tobacco products sold in India would help reduce the attractiveness of such products.
Most Popular Recent Articles
The article explains the current e-cigarette regulatory regime and proposed new Qld laws, and discusses the WHO report.
Vaish Associates Advocates
The food processing industry one of the largest industries in India is widely recognized as a 'sunrise industry' in India having huge potential for uplifting the agricultural economy, creation of large scale processed food manufacturing and food chain facilities, and the resultant generation of employment and export earnings.
Singh & Associates
Clinical research is the key to the discovery of latest diagnostic methods and to develop modern drugs for treatment of diseases.
Singh & Associates
With the objective to improvise and endow with the basic health care and availability of basic medicines at an affordable price across the country, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, , notified the Drug (Prices Control) Order 2013("DPCO 2013") in May 2013, which may fluctuate the pricing of 348 essential medicines.
Singh & Associates
In the last few years, the Indian pharmaceutical sector has seen an immense growth both in terms of domestic and international stratum.
Singh & Associates
Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
Vaish Associates Advocates
"Clinical Trials" and debates associated with it have been in headlines since past few months pursuant to the strict view taken by the apex court on the matter.
Singh & Associates
The Indian Patent office published their revised guidelines for examine the patent application in the field of Pharmaceuticals.
Singh & Associates
Abraxene is an injectible formulation of protein bound particles (paclitaxel) primarily used in the treatment of breast cancer, lung cancer and pancreatic cancer.
The Australian Federal Court in D'Arcy v Myriad Genetics Inc. has unanimously upheld a previous Federal Court decision that isolated gene sequences are patentable.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Font Size:
Mondaq on Twitter